Skip to content
DraconiticResearch
Search Sources API
201,683 studies31 sourcesUpdated 22 min ago
Peer-reviewedCC BYBiomedicines

CD47–SIRPα as a Therapeutic Target in Sarcoma: A Systematic Review of Expression, Preclinical, and Clinical Evidence

Read full textPDFCite

Related

  1. Melatonin in Musculoskeletal and Spine-Related Conditions: A Systematic Review of Preclinical and Clinical Evidence.
    Michele Bisaccia, Barbara Bifarini, Umberto Ripani +6
    Medicina (Kaunas, Lithuania)Peer-reviewedCC BYFull textPhysiologyEurope PMC
  2. Circadian rhythm and cancer-related pain: a systematic review of preclinical and clinical evidence
    Vivian Salama, Vivian Salama, Anisha Karunananthan +7
    Frontiers in Pain ResearchPeer-reviewedCC BYFull textPhysiologyDOAJ
  3. Molecular imaging tracers targeting c-MET: a systematic review of preclinical evidence and clinical translation
    Rick W. A. Verdijk, Stevie M. van der Mierde, Nataliia Berehova +5
    European Journal of Nuclear Medicine and Molecular ImagingPeer-reviewedCC BY 4.0Full textMedical imaging & radiologyPMC
  4. Therapeutic potential of escin and its nanoparticle formulations in cancer -a systematic review and meta-analysis of preclinical study
    Mao Xu, Yinju Cui, Dan Li +3
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  5. Therapeutic potential of umbilical cord-derived MSCs in arthritis: Insights from preclinical and clinical studies
    David Lawrence Greene, Umm E Habiba, Roshini Sathyanarayanan +2
    Regenerative TherapyPeer-reviewedCC BY-NC-NDFull textHuman geneticsDOAJEurope PMCEurope PMCPMC

Cite

BibTeXRIS
BibTeX
@article{anon2026cd47sirpα,
  title = {{CD47–SIRPα as a Therapeutic Target in Sarcoma: A Systematic Review of Expression, Preclinical, and Clinical Evidence}},
  journal = {Biomedicines},
  year = {2026},
  month = sep,
  url = {https://europepmc.org/article/PMC/PMC13701423},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - CD47–SIRPα as a Therapeutic Target in Sarcoma: A Systematic Review of Expression, Preclinical, and Clinical Evidence
PY  - 2026
DA  - 2026/09/27
JO  - Biomedicines
UR  - https://europepmc.org/article/PMC/PMC13701423
SN  - 2227-9059
ER  -